Compounded vs brand name: how dosing charts differ The dosing charts we have discussed so far come from FDA clinical trials of branded medications (Wegovy/Ozempic for semaglutide, Zepbound/Mounjaro for tirzepatide)
While many people lose weight with Ozempic, some may notice weight gain
Lum, assistant general counsel at Novo Nordisk
J., Vuppalanchi, R., Boursier, J., Bugianesi, E., Yoneda, M., Behling, C., Cummings, O
Mike Haney: So the clinical indication, as I understand it, for getting one of these drugs for the purpose of obesity is a BMI of 30, or a BMI of 27 with another condition like diabetes
Thats uncommon, but its a reminder that vitamin shots can still have side effects